---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-095427"
form_type: "8-K"
ticker: "VREOF"
cik: "0001771706"
company_name: "Vireo Growth Inc."
filed_at: "2026-08-13T11:00:35+00:00"
generated_at: "2026-08-13T11:05:28.715351+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Vireo closes PharmaCann Colorado acquisition (17 stores) and secures $85M BMO credit facility

## Summary
- Acquired PharmaCann Colorado retail assets for ~$48.7M: 3,004,751 subordinate voting shares plus assumed liabilities; 17 dispensaries added, footprint now 56 in Colorado.
- New $85M asset-based revolving credit facility with Bank of Montreal, expandable to $105M, maturing Aug 7, 2031; SOFR+1.75-2.00% or base+0.75-1.00%.
- Proceeds to refinance existing Chicago Atlantic debt and shareholder notes, fund working capital, capex, and permitted acquisitions.
- 61,728 Consideration Shares held back for 9 months; CEO John Mazarakis is partner of Chicago Atlantic, an affiliate of prior lender.

## SEC filing metadata
- accession: 0001104659-26-095427
- form_type: 8-K
- ticker: VREOF
- cik: 0001771706
- company_name: Vireo Growth Inc.
- filed_at: 2026-08-13T11:00:35+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.01, 2.03, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1771706/000110465926095427/0001104659-26-095427-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1771706/000110465926095427/tm2622759d4_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-095427
- JSON: https://secwatch.observer/filing/0001104659-26-095427.json
- Plain text: https://secwatch.observer/filing/0001104659-26-095427.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.